Drugs / Su yusu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06085365 | Jul 2023 → Jul 2024 | chemotherapy-induced toxicity, digestive system neoplasm | China Medical University, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Su yusu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06085365 ↗ |
| Route | Oral | “Immunonutrition （Su yusu） 250ml oral twice a day d1-d21” NCT06085365 ↗ |